DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19

IMPORTANCE: There is an unprecedented need to rapidly identify safe and effective treatments for the novel coronavirus disease 2019 (COVID-19). OBJECTIVE: To systematically investigate if any of the available drugs in Electronic Health Record (EHR), including prescription drugs and dietary supplemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bejan, Cosmin A., Cahill, Katherine N., Staso, Patrick J., Choi, Leena, Peterson, Josh F., Phillips, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872383/
https://www.ncbi.nlm.nih.gov/pubmed/33564788
http://dx.doi.org/10.1101/2021.02.04.21251169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872383/
https://www.ncbi.nlm.nih.gov/pubmed/33564788
http://dx.doi.org/10.1101/2021.02.04.21251169

Ejemplares similares